Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody-Mediated Graft Rejection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07134491
What this trial is testing

Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity

Who this might be right for
Antibody Mediated Rejection After Kidney Transplantation
Assistance Publique - Hôpitaux de Paris 45
Not applicableStudy completedNCT03737136
What this trial is testing

Comparison Between Bortezomib and Rituximab Plus Plasmapheresis in AMR

Who this might be right for
Antibody-mediated Rejection
Shahid Beheshti University of Medical Sciences 20
Not applicableStudy completedNCT03719339
What this trial is testing

VIRTUUS Children's Study

Who this might be right for
Renal Transplant RejectionPediatric Kidney DiseaseEnd Stage Renal Disease+4 more
Children's Hospital of Philadelphia 445
Testing effectiveness (Phase 2)Study completedNCT02201576
What this trial is testing

Bortezomib in Rejection of Kidney Transplants

Who this might be right for
Chronic Antibody-mediated Transplant Rejection
Assistance Publique - Hôpitaux de Paris 60
Large-scale testing (Phase 3)Study completedNCT02013037
What this trial is testing

The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation

Who this might be right for
Antibody-mediated RejectionHyperacute Rejection of Cardiac TransplantLeft Ventricular Dysfunction+2 more
Cedars-Sinai Medical Center 36
Large-scale testing (Phase 3)Active Not RecruitingNCT04561986
What this trial is testing

TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients

Who this might be right for
Antibody-mediated Rejection
Vastra Gotaland Region 50
Very early researchEnded earlyNCT03380936
What this trial is testing

Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
University of Colorado, Denver 4
Not applicableStudy completedNCT04897438
What this trial is testing

Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection

Who this might be right for
Kidney Transplant RejectionAntibody-mediated RejectionKidney Transplant Failure
Charite University, Berlin, Germany 40
Testing effectiveness (Phase 2)Study completedNCT03897205
What this trial is testing

An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients

Who this might be right for
Kidney Transplant Rejection
Hansa Biopharma AB 30
Not applicableActive Not RecruitingNCT07316829
What this trial is testing

TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS

Who this might be right for
Graft RejectionKidney TransplantationLung Transplantation+6 more
Fondazione IRCCS Policlinico San Matteo di Pavia 30
Not applicableEnded earlyNCT04711850
What this trial is testing

An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR

Who this might be right for
Kidney Transplant Rejection
Hansa Biopharma AB 18
Large-scale testing (Phase 3)Enrolling By InvitationNCT07444489
What this trial is testing

Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) or Microvascular Inflammation (MVI) (TRANSCEND/TRANSPIRE LTE)

Who this might be right for
Antibody-mediated RejectionMicrovascular Inflammation
Biogen 201
Large-scale testing (Phase 3)Enrolling By InvitationNCT06801886
What this trial is testing

Silymarin's Advantage on Graft Effectiveness

Who this might be right for
Posttransplant Diabetes MellitusAcute Graft RejectionBiopsy Proven Acute Rejection+2 more
University Hospital, Martin 130
Not applicableActive Not RecruitingNCT05184426
What this trial is testing

MuLtimodality EvaluatiOn of aNtibody mEdiated Damage in Heart Transplantation (LEONE-HT)

Who this might be right for
Transplant FailureHeart Transplant RejectionAntibody-mediated Rejection
Juan Francisco Delgado Jimenez 90
Testing effectiveness (Phase 2)WithdrawnNCT01035593
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation

Who this might be right for
Graft RejectionKidney Transplantation
Pharming Technologies B.V.
Testing effectiveness (Phase 2)Study completedNCT02474927
What this trial is testing

Combination Therapy With Carfilzomib for the Antibody-Mediated Rejection Diagnosis in Lung Transplantation

Who this might be right for
Lung Transplant Rejection
John F. McDyer, MD 22
Large-scale testing (Phase 3)Not Yet RecruitingNCT06291103
What this trial is testing

Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)

Who this might be right for
Kidney Transplant Rejection
University Hospital, Rouen 290
Large-scale testing (Phase 3)Study completedNCT02374736
What this trial is testing

Effect of Privigen Against Graft Loss

Who this might be right for
Kidney Transplantation
Assistance Publique - Hôpitaux de Paris 18
Not applicableUnknownNCT06013358
What this trial is testing

DdcfDNA in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Seoul National University Hospital 200
Testing effectiveness (Phase 2)Study completedNCT03388008
What this trial is testing

Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation

Who this might be right for
Lung Transplant RejectionAntibody-mediated Rejection
Washington University School of Medicine 27
Next Page